PYXS

$1.62

Post-MarketAs of Mar 17, 8:00 PM UTC

Pyxis Oncology, Inc., a clinical stage company, engages in the development of therapeutics to treat solid tumors.

Historical Price

Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$1.62
Potential Upside
5%
Whystock Fair Value$1.70
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryBiotechnology

Pyxis Oncology, Inc., a clinical stage company, engages in the development of therapeutics to treat solid tumors. Its lead antibody-drug conjugates (ADC) product candidate is PYX-201, an investigational novel ADC consisting of human immunoglobulin G1...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$100.87M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.46
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-87.28%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
3.93

Recent News

Simply Wall St.
Feb 6, 2026

3 Penny Stocks With Market Caps Over $50M To Watch

As February begins, major U.S. stock indexes have surged, with the Dow Jones Industrial Average adding 515 points and the S&P 500 nearing record highs. This optimistic start to the month highlights a market environment where investors are keenly exploring opportunities across various sectors. Though often seen as a relic of past trading days, penny stocks still represent significant growth potential, particularly when they come from smaller or newer companies with strong financial foundations.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Jan 7, 2026

3 Promising Penny Stocks With Market Caps Up To $300M

Major stock indexes in the United States have recently shown mixed performance, with the Dow Jones Industrial Average and S&P 500 setting fresh all-time highs. Amid these fluctuating market conditions, investors are increasingly exploring diverse opportunities to maximize potential returns. Penny stocks, though a term from earlier market days, continue to represent intriguing investment prospects by offering access to smaller or newer companies at lower price points. By identifying those with...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
MT Newswires
Dec 18, 2025

Wall Street Set to Open Higher Thursday as Inflation Rises Less Than Expected; Jobless Claims Decline

US stocks look set to open higher in Thursday's trading session as investors dissect key inflation a

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
MT Newswires
Dec 18, 2025

Investors Await Key Inflation, Employment Data as US Futures Rise Thursday Pre-Bell

US stock futures are rising in Thursday's premarket session as investors await key inflation data an

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Dec 9, 2025

3 Promising Penny Stocks With Over $90M Market Cap

As the U.S. stock market experiences fluctuations with investors closely monitoring the Federal Reserve's impending decision on interest rates, many are seeking opportunities in less conventional areas of investment. Penny stocks, a term that might seem outdated but remains significant, often represent smaller or newer companies with potential for growth at accessible price points. These stocks can offer intriguing prospects when they possess strong financial health and solid fundamentals,...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.